![]() Aldeyra Therapeutics Aldeyra Therapeutics develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases. | |||
Founding Date | Founding Date 2012 | Founding Date 2004 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Sandwich, GB HQ | Locations Lexington, US HQ | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 1958% increase | Employees 324187% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 333.9 m | Valuation ($) 359.6 m |
Financial | |||
Cost of goods | Cost of goods £3.3m (FY, 2015) | Cost of goods N/A | Cost of goods $39.5m (FY, 2025) |
Net income | Net income (£3.7m) (FY, 2015) | Net income ($33.8m) (FY, 2025) | Net income ($5.3m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 16.1m | Total funding raised $ 7.8m | Total funding raised N/A |

Aldeyra Therapeutics develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases.
View company
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company